Literature DB >> 15178930

Natural history of frontotemporal dementia: comparison with Alzheimer's disease.

Florence Pasquier1, Florence Richard, Florence Lebert.   

Abstract

INTRODUCTION: Frontotemporal dementia (FTD) is a more common cause of dementia than previously recognised. Few data are available regarding the natural course of FTD in terms of survival, nursing home admission and causes of death.
METHODS: An observational study of all consecutive patients referred to the memory centre of Lille, France, between 1995 and 1999, and examined at least twice in this centre, with a diagnosis of FTD (frontal or behavioural variant) or of Alzheimer's disease (AD) was performed. Kaplan-Meyer analysis allowing for delayed entry was used to compare the survival functions in FTD and AD.
RESULTS: 552 patients were included, of whom 49 (8.9%) were lost to follow-up at 3 years. FTD patients were younger (mean age at onset 59 years), had more often a family history of psychiatric disorders (20%), had a longer delay between first symptoms and first visit (5.9 years) and a higher Mini-Mental State Examination (MMSE) score at first visit (24.5) than patients with AD (19.9). The mean annual MMSE score decline was 0.9 point in FTD vs. 2.0 points in AD (p < 0.0004). Fewer patients with FTD than with AD entered an institution (RR: 0.20, 95% CI 0.05-0.81). After adjustment for sex, age at first visit, level of education and MMSE score at first visit, survival rates in FTD and AD did not differ significantly. Patients with FTD often had a sudden death, the cause of which could not be found. The earlier the first visit after onset, the longer the survival rate, whatever the diagnosis (RR: 0.76, 95% CI 0.67-0.86, p < 0.0001 per year of earlier first visit).
CONCLUSION: This large study showed that the mean duration of FTD was 2 years longer than that of AD, but the risk of death after adjustment for age and sex was similar in FTD and in AD. Sudden and unexplained causes of death were frequent and need further study. Early management increases the life span of demented patients. Copyright 2004 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2004        PMID: 15178930     DOI: 10.1159/000077148

Source DB:  PubMed          Journal:  Dement Geriatr Cogn Disord        ISSN: 1420-8008            Impact factor:   2.959


  21 in total

1.  What is the life expectancy in frontotemporal lobar degeneration?

Authors:  Chiadi U Onyike
Journal:  Neuroepidemiology       Date:  2011-11-02       Impact factor: 3.282

2.  Lipid lowering agents are associated with a slower cognitive decline in Alzheimer's disease.

Authors:  I Masse; R Bordet; D Deplanque; A Al Khedr; F Richard; C Libersa; F Pasquier
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-12       Impact factor: 10.154

3.  MMSE scores decline at a greater rate in frontotemporal degeneration than in AD.

Authors:  Tiffany W Chow; Linda S Hynan; Anne M Lipton
Journal:  Dement Geriatr Cogn Disord       Date:  2006-08-07       Impact factor: 2.959

Review 4.  Neuropsychological differences between frontotemporal dementia and Alzheimer's disease: a review.

Authors:  Michal Harciarek; Krzysztof Jodzio
Journal:  Neuropsychol Rev       Date:  2005-09       Impact factor: 7.444

Review 5.  The birth and early evolution of the frontotemporal dementia (FTD) concept.

Authors:  Arne Brun; Lars Gustafson
Journal:  J Mol Neurosci       Date:  2011-06-07       Impact factor: 3.444

6.  Factors affecting survival of patients with neurodegenerative disease.

Authors:  Kyle Steenland; Jessica MacNeil; Ryan Seals; Allan Levey
Journal:  Neuroepidemiology       Date:  2010-04-08       Impact factor: 3.282

Review 7.  The path to biomarker-based diagnostic criteria for the spectrum of neurodegenerative diseases.

Authors:  Filippo Baldacci; Sonia Mazzucchi; Alessandra Della Vecchia; Linda Giampietri; Nicola Giannini; Maya Koronyo-Hamaoui; Roberto Ceravolo; Gabriele Siciliano; Ubaldo Bonuccelli; Fanny M Elahi; Andrea Vergallo; Simone Lista; Filippo Sean Giorgi; Harald Hampel
Journal:  Expert Rev Mol Diagn       Date:  2020-02-27       Impact factor: 5.225

8.  A case study of an emerging visual artist with frontotemporal lobar degeneration and amyotrophic lateral sclerosis.

Authors:  Anli Liu; Kelly Werner; Subhojit Roy; John Q Trojanowski; Ursula Morgan-Kane; Bruce L Miller; Katherine P Rankin
Journal:  Neurocase       Date:  2009-06       Impact factor: 0.881

9.  Differential longitudinal decline on the Mini-Mental State Examination in frontotemporal lobar degeneration and Alzheimer disease.

Authors:  Kay See Tan; David J Libon; Katya Rascovsky; Murray Grossman; Sharon X Xie
Journal:  Alzheimer Dis Assoc Disord       Date:  2013 Oct-Dec       Impact factor: 2.703

10.  Volumetric MRI and cognitive measures in Alzheimer disease : comparison of markers of progression.

Authors:  Basil H Ridha; Valerie M Anderson; Josephine Barnes; Richard G Boyes; Shona L Price; Martin N Rossor; Jennifer L Whitwell; Lisa Jenkins; Ronald S Black; Micheal Grundman; Nick C Fox
Journal:  J Neurol       Date:  2008-02-18       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.